Immunic AG | WebDisclosure

Basculer en Français

10855	Companies
235909	Keywords
164857	Articles
126468	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 09/09/2025 at 12:30, 11 months 10 days ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic receives United States Patent Notice of Allowance for Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis, extending protection into 2041

United States Patent Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Patent Notice Of Allowance
BRIEF

published on 09/04/2025 at 12:35, 11 months 15 days ago

Immunic annonce sa participation à des conférences clés

Réunions D'investisseurs Immunique Vidofludimus Calcique ECTRIMS 2025 Conférence Biopharmaceutique
BRIEF

published on 09/04/2025 at 12:35, 11 months 15 days ago

Immunic Announces Participation in Key Conferences

Immunic Vidofludimus Calcium Investor Meetings Biopharma Conference ECTRIMS 2025
PRESS RELEASE

published on 09/04/2025 at 12:30, 11 months 15 days ago

Immunic to Participate in Investor and Scientific Conferences in September
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in September, including H.C. Wainwright 27th Annual Global Investment Conference and ECTRIMS Congress

Investor Conference Clinical Pipeline Scientific Conference Immunic Inc ECTRIMS Congress
BRIEF

published on 08/07/2025 at 12:35, 1 year ago

Immunic publie ses résultats financiers du deuxième trimestre 2025 avec les progrès du Vidofludimus Calcium

Essais Sur La Sclérose En Plaques Dépenses De R&D Vidofludimus Calcique Résultats Financiers D'Immunic Investissement Dans Les Biotechnologies
BRIEF

published on 08/07/2025 at 12:35, 1 year ago

Immunic Reports Q2 2025 Financial Results with Vidofludimus Calcium Progress

Vidofludimus Calcium Multiple Sclerosis Trials R&D Expenses Biotech Investment Immunic Financial Results
PRESS RELEASE

published on 08/07/2025 at 12:30, 1 year ago

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports positive Q2 2025 results with focus on clinical progress of vidofludimus calcium for multiple sclerosis treatment

Clinical Trials Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Q2 2025 Results
BRIEF

published on 06/24/2025 at 12:35, 1 year 1 month ago

Immunic Releases Promising Long-Term Data on Vidofludimus Calcium for MS

Multiple Sclerosis Vidofludimus Calcium Phase 2 Trial Long-Term Data Neurological Function
BRIEF

published on 06/24/2025 at 12:35, 1 year 1 month ago

Immunic publie des données prometteuses à long terme sur le vidofludimus calcique pour la sclérose en plaques

Sclérose En Plaques Essai De Phase 2 Vidofludimus Calcique Données À Long Terme Fonction Neurologique
PRESS RELEASE

published on 06/24/2025 at 12:30, 1 year 1 month ago

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Immunic reports positive long-term data from phase 2 EMPhASIS Trial of Vidofludimus Calcium in relapsing-remitting multiple sclerosis, showing favorable safety & tolerability profile up to 5.5 years

Multiple Sclerosis Immunic Vidofludimus Calcium Safety EMPhASIS Trial

Accesswire

Published on 08/20/2026 at 02:22, 6 hours 8 minutes ago

Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 01:00, 7 hours 30 minutes ago

Irving Resources Announces Results of AGM
Published on 08/20/2026 at 00:40, 7 hours 50 minutes ago

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 10 hours 30 minutes ago

Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 11 hours 55 minutes ago

Revive Therapeutics Announces Proposed Shares for Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 08/20/2026 at 08:15, 15 minutes ago

The Platform Group continues profitable growth in H1 2026 - organic growth strengthens profitability and cash flow
Published on 08/20/2026 at 08:00, 30 minutes ago

Genel Energy PLC: Notification of Proposed Transfer from the Equity Shares (Transition) Category to the Equity Shares (Commercial Companies) Category
Published on 08/20/2026 at 07:45, 45 minutes ago

Mayr-Melnhof Karton AG: MM reports half-year results for 2026
Published on 08/20/2026 at 07:30, 1 hour ago

tonies extends lead in North America and increases global revenue by 41% in H1 2026 – exceptional demand for Toniebox 2 fuels strong growth dynamic
Published on 08/20/2026 at 07:00, 1 hour 30 minutes ago

1H26: Swiss Prime Site delivers a strong operating result and sustained growth; FFO I of CHF 2.15 per share (+2.4%)

Les Echos

Published on 08/18/2026 at 18:00, 1 day 14 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 14 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 21 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 21 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 12 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE